EFFECT OF SILVER NANOPARTICLES ON LEVELS OF SERUM FSH, LH AND ESTRADIOL IN PCO-INDUCED FEMALE MICE
Journal Title: World Journal of Pharmaceutical Research - Year 2017, Vol 6, Issue 11
Abstract
This study was conducted to investigate the effect of two concentrations (0.5 and 1ppm) of silver nanoparticles on levels of serum FSH, LH and E2 in PCO-induced female mice. A number(n=80) of mature female mice were intraperitoneally injected with human Chorionic Gonadotropin (hCG) at a dose of (10 IU/ mL) three days a week for two weeks in order to induce PCO. Then, these mice were divided into two groups, according to the duration of treatment (30, 45 days). Each group was subdivided to subgroups according to the substance administrated. Two subgroups were treated with (0.5 and 1ppm) of silver NPs solution by (i.p) injection twice a week and the third subgroup was treated with metformin at a dose of (1mg/day) orally three days a week. Results: there was a significant reduction (P<0.05) in serum levels of FSH in the PCO group treated with (1ppm) of silver NPs for 30 days as compared to the control. While, a significant elevation (P< 0.05) was observed in levels of E2, for the same group as compared to the control. The PCO group treated with (0.5ppm) recorded a significant reduction (P <0.05) in serum levels of E2 for the same duration. But longer duration (45 days) exhibited a significant elevation (P< 0.05) in levels serum of FSH in the PCO-induced mice treated with (0.5ppm) of silver NPs which, was similar to the effect of metformin. A significant elevation (P> 0.05) in serum levels of FSH was observed in the PCO group treated with (0.5ppm) of silver NPs along 30 days as compared to their similar group that was treated along 45 days but, non significant alteration (P> 0.05) were observed in serum levels of LH or E2 between groups of the (30 days) duration as compared to their similar groups of the second duration (45 days). Conclusion: There were significant alterations in levels of serum FSH, LH and E2 in the PCO-induced mice treated with both concentrations of silver NPs as compared to the control.
Authors and Affiliations
Prof. Suzan I. Bajilan
Keywords
Related Articles
- EP ID EP618224
- DOI -
- Views 171
- Downloads 0
ETIOPATHOGENESIS & SHATKRIYAKALA OF MUTRAGHATA (RETENTION OF URINE): A REVIEW STUDY
Now a days, it is seems that several patients are suffering from different types of disorders of Mutravaha Srotas. So, each physician should know the details like nidana (etiological factor), samprapti (pathogenesis), la...
DIAGNOSTIC METHOD OF CHRONIC MERCURY TOXICITY AND ITS AYURVEDIC MANAGEMENT
Long term hazards due to prolong persistent continuous exposure of mercury causes chronic cumulative toxicity in human beings. Heavy industrialization, gold mining, utilization of fishes as a food containing methyl mercu...
PHARMACEUTICAL APPROACHES OF IL-6 INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS, FOCUS ON NEW FDA APPROVED DRUG: SARILUMAB
Rheumatoid arthritis (RA) is a chronic inf1ammatory disease of unknown etiology and the most common form of chronic inflammatory arthritis and often results in joint damage and physical disability. RA is characterized by...
REFRACTIVE ERRORS: EPIDEMIOLOGICAL PROFILE IN CHILDREN IN MADAGASCAR
Background: Refractive error can lead amblyopia in children. The aim of study is to evaluate epidemological status of refractive error in children. Methods: It was a cross-sectional, descriptive study done in two Antanan...
THE APPROVAL OF DRUG PROCESS: A REVIEW
It takes on average 12 years and over US$350 million to get a new drug from the laboratory onto the pharmacy shelf. Once a company develops a drug, it undergoes around three and a half years of laboratory testing, before...